Seagen

Youtube Subscribe

Open: 198.0 Close: 196.54 Change: -1.46

Don't invest before reading what an AI found about Seagen Stock.

This document will help you to evaluate Seagen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Seagen are: Seagen, company, Inc, year, Pfizer, price, cancer, and the …

Concept Map

Semantic Network

Stock Summary

Seagen Inc. develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors. It has collaboration agreements with Takeda.

Today's Summary

Seagen Inc. reports financial results for first quarter ended March 31, 2023. Seagen revenue was $1.96 billion, an increase of 24.65% compared to the previous years. Pfizer plans to acquire Bothell, Wash. biotech company Seagen.

Today's News

Seagen Inc. (Nasdaq:SGEN) (Seagen or the Company) reported financial results today for the first quarter ended March 31, 2023. Seagens revenue was $1.96 billion, an increase of 24.65% compared to the previous years. Price Target $189.73 (-3.46% downside) Pfizer plans to acquire Bothell, Wash. biotech company Seagen. Rowley Law PLLC is investigating potential securities law violations by Seagen Inc. Seagen stock price, company overview & news. Seagen Inc. reports financial results for first quarter ended March 31, 2023. FDA approves combination regimen of Mercks Keytruda and Seagen and Astellas Padcev for first-line treatment of locally advanced or metastatic urothelial cancer. Pfizer-Seagen deal faces regulatory hurdles as FTC review extended Pfizers acquisition of Seagen faces regulatory. Pfizer and Seagen have also referred their deal to European regulators. Seagen disclaims any intention or obligation to update or revise any forward-looking statements. More information about the risks and uncertainties faced by Seagen is contained under the caption “Risk Factors” included in Seagens Quarterly Report on Form 10-Q. Seagen stock started trading at the price of $198.00 on Monday morning 06/26/2023. Compared to the closing price on Friday 06/23/20th on NAS, this is a drop of 0.11%. There are 187.50 M shares outstanding in Seagen, which values the company at $37.19 B. Seagen is a global biotechnology company dedicated to revolutionizing cancer care. Seagen does not necessarily endorse the organization associated with this link. Astellas and Seagen announce China National Medical Products Administration accepts Biologics License Application for Enfortumab Vedotin in certain patients with Locally Advanced or Metastatic Urothelial Cancer (la/mUC) Seagen (NASDAQ:SGEN) shareholders have earned a 29% CAGR over the last five years. Investors in Seagen have made a incredible return of 307% over the past five years Long term investing can be life changing when you buy and hold the truly great businesses. Pfizer has announced its plans to acquire Seattle-based Seagen for a whopping $43 billion in a blockbuster deal that brings together two industry giants. Seagen is known for its expertise in a type of cancer therapy known as an antibody-drug conjugate.

Stock Profile

"Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington."

Keywords

Are looking for the most relevant information about Seagen? Investor spend a lot of time searching for information to make investment decisions in Seagen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Seagen are: Seagen, company, Inc, year, Pfizer, price, cancer, and the most common words in the summary are: seagen, stock, inc, best, pfizer, cancer, buy, . One of the sentences in the summary was: Seagen Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #seagen #stock #inc #best #pfizer #cancer #buy.

Read more →

Youtube Subscribe

---